| Non-vaccinated uninfected (n = 10) | Non-vaccinated infected (n = 10) | Vaccinated control (n = 5) | Vaccinated uninfected (n = 18) | Vaccinated infected (n = 2) | |
---|---|---|---|---|---|---|
 | aIgG1 (SP%) | 0.49 | 10.75 | 54.39 | 91.09 | 52.2 |
Up regulated | LYN | 2.1 | 1.2 | Â | 1.4 | 1.6 |
GRB2 | 1.8 | Â | Â | Â | 1.4 | |
ERG1 | Â | Â | Â | Â | Â | |
JUN | Â | 1.4 | Â | Â | 1.1 | |
NFIL3 | Â | 2.2 | Â | 1.4 | 2.8 | |
LCK | 1.5 | 3.2 | Â | Â | Â | |
CD81 | 1.5 | 1.9 | Â | Â | Â | |
CD84 | Â | 3.8 a | Â | Â | Â | |
CD40LG | 2.5 | 5 | Â | Â | 5 | |
BAFF | 1.5 | 5 b | Â | Â | 2.2 | |
MIF | 1.1 | 2.4 | Â | Â | 1.3 | |
Down regulated | LYN |  |  | −1.8 |  |  |
GRB2 |  | −1.2 | −3 | −1.1 |  | |
ERG1 | −1.7 | −3.8 | −3.3 | −1.4 | −1.7 | |
JUN | −1.4 |  | −1.9 | − 1.1 |  | |
NFIL3 | −1.1 |  | −1.6 |  |  | |
LCK |  |  | −2.8 | −1 | − 1.1 | |
CD81 |  |  | −3.6 | −1.6 | − 1.2 | |
CD84 | −1.1 |  | −2.1 | −2.4 a | −1.1 | |
CD40LG |  |  | −1.1 | − 1 |  | |
BAFF |  |  | −1.2 | -1 b |  | |
MIF |  |  | −2.9 | −1.7 |  |